The GPHF-Minilab™ - Background Information on Counterfeit Medicines
Selected Literature
- Surveillance for substandard and falsifed medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab (www.nature.com, 2022)
- Falsified and Substandard Drugs: Stopping the Pandemic - Article from The American Journal of Tropical Medicine and Hygiene, March 2019
- The Analytical Scientist 2018: Taking Down A Goliath (Report on Dr. Jähnke and his work with the GPHF-Minilab™)
- WHO 2017: Global Surveillance and Monitoring System for Substandard and Falsified Medical Products (Executive Summary)
- WHO 2017: A Study on the Public Health And Socioeconomic Impact of Substandard and Falsified Medical Products (Executive Summary)
- WHO Medical Product Alert 4/2017: Fake Penicillin-V Tablets detected with Minilab in Cameroon
- PLOS ONE 2017: Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab
- WHO Medical Product Alert 2/2017: Falsified quinine tablets detected with Minilabs in Africa
- Medicine Access @ Point of Care 2017: What's in a word? Falsified/counterfeit/fake medicines - the definitions debate
- WHO Medical Product Alert 2016: Falsified quinine tablets detected with Minilabs in West and Central Africa
- Malaria Journal 2016: Detecting counterfeit antimalarial medicines in Malawi using Minilab technology
- USP Promoting the Quality of Medicines Programme 2015: Monitoring the quality of medicines - Results from Africa, Asia and South America
- The Federal Agency for Physical Testing in Germany 2015: Postmarketing surveillance systems for pharmaceuticals in the East African Community
- The Lancet 2014: Falsified Medicines in Africa: All Talk, No Action
- Malaria Journal 2014: Poor-Quality Anti-malarials in the Malarious World
- WHO Drug Alerts 2014: Falsified antimalarial medicines in west and central Africa
- WHO Drug Alerts 2013: Falsified batches of Coartem circulating in Western and Central Africa
- SEA J. Trop. Med. & Pub. Health, May 2013: The quality of antimalarial medicines in Western Cambodia
- SEA J. Trop. Med. & Pub. Health, May 2013: The quality of antimalarial medicines in Eastern Thailand
- Int J Tuberc Lung Disease, Jan 2013: Substandard and falsified anti-tuberculosis drugs
- British Medical Journal 2012: How to achieve international action on falsified and substandard medicines
- The Lancet 2012: Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
- Malaria Journal 2011: Poor quality vital anti-malarials in Africa
- Interpol 2010: Fact sheet on pharmaceutical crime
- Chatham House Project 2010: Ways to define and combat counterfeit medicines
- WHO 2010: 25 Years of Involvement in Combating Counterfeit Medicines
- Wellcome Trust 2009: Counterfeit Medicines - Perspectives and Action
- USP DQI 2009: Capacity Building for Health Authorities in Africa and Asia using GPHF-Minilabs
- GPHF 2008: Minilab Project Review and South Sudan Mission
- WHO/IMPACT 2008: Counterfeit Drugs Kill
- Interpol/WHO IMPACT 2008: Seizure of counterfeit medicines in East Africa (Operation Mamba)
- Interpol/WHO IMPACT 2008: Seizure of counterfeit medicines in South East Asia (Operation Storm)
- WHO/IMPACT 2007: Counterfeit Drugs Kill
- WHO/IMPACT 2006: Estimates on Counterfeit Medicines Proliferation
- WHO 2006: Counterfeit Medicines Definition and Facts
- GPHF 2006: Protection Against Counterfeit Pharmaceuticals with Minilabs in Low-income Countries
- GPHF 2005: Use of Minilabs in South East Asia
- World Bank 2005: Pharmaceuticals - Quality Assurance in the Distribution Chain
- World Bank 2005: Pharmaceuticals - Counterfeits, Substandard Drugs and Drug Diversion
- Nature 2005: Murder by Medicines
- GPHF 2004: Counterfeit Medicines - An Unscrupulous Business
- GPHF 2002: Use of Minilabs in Nepal
- Wellcome Trust 2001: Fake Artesunate In Southeast Asia
- WHO 1999: The Problem of Counterfeited Medicines
- WHO 1999: Guidelines to Combat and Test Counterfeit Medicines
- WHO 1992: Joint IFPMA workshop on counterfeit medicines - report and recommendations